Cargando…

Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk

Background and Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection represents a pathology with primary pulmonary involvement and multisystemic impact, including cardiovascular injuries. The present study aimed to assess the value of clinical, biochemical, and imaging f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumea, Eduard, Lazar, Mihai, Barbu, Ecaterina Constanta, Chitu, Cristina Emilia, Ion, Daniela Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610985/
https://www.ncbi.nlm.nih.gov/pubmed/36295594
http://dx.doi.org/10.3390/medicina58101436
_version_ 1784819414400499712
author Dumea, Eduard
Lazar, Mihai
Barbu, Ecaterina Constanta
Chitu, Cristina Emilia
Ion, Daniela Adriana
author_facet Dumea, Eduard
Lazar, Mihai
Barbu, Ecaterina Constanta
Chitu, Cristina Emilia
Ion, Daniela Adriana
author_sort Dumea, Eduard
collection PubMed
description Background and Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection represents a pathology with primary pulmonary involvement and multisystemic impact, including cardiovascular injuries. The present study aimed to assess the value of clinical, biochemical, and imaging factors in COVID-19 patients in determining the severity of myocardial involvement, and to create a model that can be used toevaluate myocardial injury risk based on clinical, biochemical and imaging factors. Materials and Methods: We performed an observational cohort study on 150 consecutive patients, evaluating their age, sex, hospitalization period, peripheral oxygen saturation (SpO(2)) in ambient air, systolic and diastolic blood pressure, heart rate, respiratory rate, biochemical markers of cardiac dysfunction (TnI, and NT-proBNP), inflammatory markers (C reactive protein (CRP), fibrinogen, serum ferritin, interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα)), D-dimers, lactate dehydrogenase (LDH), myoglobin and radio-imaging parameters. All patients underwent computerized tomography chest scan in the first two days following admission. Results: We observed elevated heart and respiratory rates, higher systolic blood pressure, and a lower diastolic blood pressure in the patients with cardiac injury; significant differences between groups were registered in TnI, NT-proBNP, LDH, CRP, and D-dimers. For the radiological parameters, we found proportional correlations with the myocardial injury for the severity of lung disease, number of pulmonary segments with alveolar consolidation, number of pulmonary lobes with pneumonia, crazy paving pattern, type of lung involvement, the extent of fibroatelectatic lesions and the mediastinal adenopathies. Conclusions: Myocardial injury occurred in 12% of patients in the study group. Ground glass opacities, interstitial interlobular septal thickening (crazy paving pattern), fibroatelectasic lesions and alveolar consolidations on CT scan were correlated with myocardial injury. Routine lung sectional imaging along with non-specific biomarkers (LDH, D-dimers, and CRP) can be further valuable in the characterization of the disease burden, thus impacting patient care.
format Online
Article
Text
id pubmed-9610985
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96109852022-10-28 Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk Dumea, Eduard Lazar, Mihai Barbu, Ecaterina Constanta Chitu, Cristina Emilia Ion, Daniela Adriana Medicina (Kaunas) Article Background and Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection represents a pathology with primary pulmonary involvement and multisystemic impact, including cardiovascular injuries. The present study aimed to assess the value of clinical, biochemical, and imaging factors in COVID-19 patients in determining the severity of myocardial involvement, and to create a model that can be used toevaluate myocardial injury risk based on clinical, biochemical and imaging factors. Materials and Methods: We performed an observational cohort study on 150 consecutive patients, evaluating their age, sex, hospitalization period, peripheral oxygen saturation (SpO(2)) in ambient air, systolic and diastolic blood pressure, heart rate, respiratory rate, biochemical markers of cardiac dysfunction (TnI, and NT-proBNP), inflammatory markers (C reactive protein (CRP), fibrinogen, serum ferritin, interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα)), D-dimers, lactate dehydrogenase (LDH), myoglobin and radio-imaging parameters. All patients underwent computerized tomography chest scan in the first two days following admission. Results: We observed elevated heart and respiratory rates, higher systolic blood pressure, and a lower diastolic blood pressure in the patients with cardiac injury; significant differences between groups were registered in TnI, NT-proBNP, LDH, CRP, and D-dimers. For the radiological parameters, we found proportional correlations with the myocardial injury for the severity of lung disease, number of pulmonary segments with alveolar consolidation, number of pulmonary lobes with pneumonia, crazy paving pattern, type of lung involvement, the extent of fibroatelectatic lesions and the mediastinal adenopathies. Conclusions: Myocardial injury occurred in 12% of patients in the study group. Ground glass opacities, interstitial interlobular septal thickening (crazy paving pattern), fibroatelectasic lesions and alveolar consolidations on CT scan were correlated with myocardial injury. Routine lung sectional imaging along with non-specific biomarkers (LDH, D-dimers, and CRP) can be further valuable in the characterization of the disease burden, thus impacting patient care. MDPI 2022-10-11 /pmc/articles/PMC9610985/ /pubmed/36295594 http://dx.doi.org/10.3390/medicina58101436 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dumea, Eduard
Lazar, Mihai
Barbu, Ecaterina Constanta
Chitu, Cristina Emilia
Ion, Daniela Adriana
Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk
title Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk
title_full Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk
title_fullStr Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk
title_full_unstemmed Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk
title_short Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk
title_sort pulmonary involvement in sars-cov-2 infection estimates myocardial injury risk
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610985/
https://www.ncbi.nlm.nih.gov/pubmed/36295594
http://dx.doi.org/10.3390/medicina58101436
work_keys_str_mv AT dumeaeduard pulmonaryinvolvementinsarscov2infectionestimatesmyocardialinjuryrisk
AT lazarmihai pulmonaryinvolvementinsarscov2infectionestimatesmyocardialinjuryrisk
AT barbuecaterinaconstanta pulmonaryinvolvementinsarscov2infectionestimatesmyocardialinjuryrisk
AT chitucristinaemilia pulmonaryinvolvementinsarscov2infectionestimatesmyocardialinjuryrisk
AT iondanielaadriana pulmonaryinvolvementinsarscov2infectionestimatesmyocardialinjuryrisk